4848

Irish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. agreed to pay more than 43 million to settle multistate litigation alleging that they illegally promoted the epilepsy drug Zonegran for uses not approved by the Food and Drug Administration and that this caused false claims to be submitted to state Medicaid programs. This was part of a larger 203 million civil and criminal settlement involving the federal government; ###-elan-corporation-plc